Authors: Petersen, TR Buus, S Brunak, S Nissen, MH Sherman, LA Claesson, MH

Citation: Tr. Petersen et al., Identification and design of p53-derived HLA-A2-binding peptides with increased CTL immunogenicity, SC J IMMUN, 53(4), 2001, pp. 357-364

Authors: Bregenholt, S Petersen, TR Claesson, MH

Citation: S. Bregenholt et al., The majority of lamina propria CD4(+) T-cells from scid mice with colitis undergo Fas-mediated apoptosis in vivo, IMMUNOL LET, 78(1), 2001, pp. 7-12

Authors: Thulesen, S Nielsen, M Petersen, TR Nissen, MH Odum, N Ropke, C

Citation: S. Thulesen et al., Interleukin 15 is a growth factor for human thymocytes with preferential effect on CD8(+) cells, CYTOKINE, 12(6), 2000, pp. 751-755

Authors: Barfoed, AM Petersen, TR Kirkin, AF Straten, PT Claesson, MH Zeuthen, J

Citation: Am. Barfoed et al., Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p53(65-73) wild type peptide loaded on dendritic cells in vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 protein, SC J IMMUN, 51(2), 2000, pp. 128-133

Authors: Petersen, TR Bregenholta, S Pedersen, LO Nissen, MH Claesson, MH

Citation: Tr. Petersen et al., Human p53(264-272) HLA-A2 binding peptide is an immunodominant epitope in DNA-immunized HLA-A2 transgenic mice, CANCER LETT, 137(2), 1999, pp. 183-191